Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP209571.RAWVfbTz6-fEM8OyTp2e_Z2hWPjC04J18YdELQ6-Tljxo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP209571.RAWVfbTz6-fEM8OyTp2e_Z2hWPjC04J18YdELQ6-Tljxo130_assertion type Assertion NP209571.RAWVfbTz6-fEM8OyTp2e_Z2hWPjC04J18YdELQ6-Tljxo130_head.
- NP209571.RAWVfbTz6-fEM8OyTp2e_Z2hWPjC04J18YdELQ6-Tljxo130_assertion description "[Patients with NF1 and MEN 2 could be discriminated from those with VHL, SDHB, and SDHD gene mutations in 99% of cases by the combination of normetanephrine and metanephrine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP209571.RAWVfbTz6-fEM8OyTp2e_Z2hWPjC04J18YdELQ6-Tljxo130_provenance.
- NP209571.RAWVfbTz6-fEM8OyTp2e_Z2hWPjC04J18YdELQ6-Tljxo130_assertion evidence source_evidence_literature NP209571.RAWVfbTz6-fEM8OyTp2e_Z2hWPjC04J18YdELQ6-Tljxo130_provenance.
- NP209571.RAWVfbTz6-fEM8OyTp2e_Z2hWPjC04J18YdELQ6-Tljxo130_assertion SIO_000772 21262951 NP209571.RAWVfbTz6-fEM8OyTp2e_Z2hWPjC04J18YdELQ6-Tljxo130_provenance.
- NP209571.RAWVfbTz6-fEM8OyTp2e_Z2hWPjC04J18YdELQ6-Tljxo130_assertion wasDerivedFrom befree-20140225 NP209571.RAWVfbTz6-fEM8OyTp2e_Z2hWPjC04J18YdELQ6-Tljxo130_provenance.
- NP209571.RAWVfbTz6-fEM8OyTp2e_Z2hWPjC04J18YdELQ6-Tljxo130_assertion wasGeneratedBy ECO_0000203 NP209571.RAWVfbTz6-fEM8OyTp2e_Z2hWPjC04J18YdELQ6-Tljxo130_provenance.